Gusperimus

DB12692InvestigationalSmall molecule

Gusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.

Chemical structure of Gusperimus
Formula / weight
C17H37N7O3 · 387.529 g/mol (avg)

Resolves to

Compound
UNIIUJ0ZJ76DO9CAS98629-43-7ChEMBLCHEMBL406117ChEBI135609PubChem55362
Clinical / RWD
ATCL04AA19
Structure
InChIKeyIDINUJSAMVOPCM-UHFFFAOYSA-NSMILESNCCCNCCCCNC(=O)C(O)NC(=O)CCCCCCNC(N)=N

What you can answer from here — as of September 23, 2026

400Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 10 drug categories
Sign in

Which companies are running trials of Gusperimus, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In